Golgi - About the company
Golgi is an unfunded company based in San Francisco (United States), founded in 2023. It operates as a Provider of computational platform for mass spectrometry proteomics. Golgi has not raised any funding yet. The company has 12 active competitors, including 3 that are funded. Its top competitors include companies like Algorithmiq, Code Ocean and Tamarind Bio.
Company Details
Provider of computational platform for mass spectrometry proteomics. It offers a solution for processing and analyzing biological information. Its tools are enabling researchers to gain deeper insights from the proteomics data. The platform leverages AI and machine learning techniques to accelerate the drug discovery process by identifying promising drug candidates, predicting drug properties, and optimizing drug molecules.
Key Metrics
Founded Year
2023
Location
San Francisco, United States
Stage
Unfunded
Ranked
10th among 12 active competitors
Similar Companies
Golgi's funding and investors
Golgi has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Golgi's Competitors and alternates
Top competitors of Golgi include Algorithmiq, Code Ocean and Tamarind Bio. Here is the list of Top 10 competitors of Golgi, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
---|---|---|---|---|---|
1st | Algorithmiq 2020, Helsinki (Finland), Series A | Provider of quantum computing algorithms for the life science sector | $20M | 48/100 | |
2nd | Code Ocean 2014, New York City (United States), Series B | Provider of cloud based platform for the development of algorithms | $48.6M | 37/100 | |
3rd | Tamarind Bio 2023, San Francisco (United States), Series A | Provider of a no-code bioinformatics platform for life scientists | $13.6M | 30/100 | |
4th | ZMT Zurich MedTech 2006, Zurich (Switzerland), Unfunded | Provider of simulation-based software solutions for targeted life science applications | - | - | 17/100 |
5th | Platforma.bio 2024, San Francisco (United States), Unfunded | Provider of a computational biology platform to simplify data analysis for biologists | - | - | 15/100 |
7th | Digital platform for the optimization of Gene Expression using computational approaches | - | - | 10/100 | |
8th | Huggins Lab 2021, New York City (United States), Unfunded | Provider of collaboration tools for R&D in computational research | - | - | 10/100 |
9th | BioDepot 2019, Seattle (United States), Unfunded | Cloud based platform offering big data analytics solutions | - | - | 10/100 |
10th | LumiNet Bio 2022, Toronto (Canada), Unfunded | AI-powered integrative computational biology platform | - | - | 10/100 |
10th | Golgi 2023, San Francisco (United States), Unfunded | Provider of computational platform for mass spectrometry proteomics | - | - | 10/100 |
Looking for more details on Golgi's competitors? Click here to see the top ones
Golgi's Investments and acquisitions
Golgi has made no investments or acquisitions yet.
Reports related to Golgi
Here is the latest report on Golgi's sector:
Are you a Founder ?
FAQ's about Golgi
Explore our recently published companies
- Orimi - Russia based, 1994 founded, Unfunded company
- Bharatheeyam Security Services - Chennai based, 2007 founded, Unfunded company
- FroGo - Gurugram based, 2022 founded, Seed company
- G4S - London based, 1901 founded, Acquired company
- TAX INSIGHT - Warszowice based, 2015 founded, Unfunded company
- Discover Me - Frankston based, 2002 founded, Funding Raised company